OpGen, Inc.
(NASDAQ : OPGN)

( )
OPGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
MARAMarathon Patent Group, Inc. -6.19%30.030.5%$928.74m
ETSYEtsy, Inc. 1.11%200.307.5%$548.80m
TALTAL Education Group 1.23%76.040.8%$241.51m
CHGGChegg, Inc. -0.96%87.7413.5%$205.57m
FLTFLEETCOR Technologies, Inc. 1.59%282.633.6%$201.92m
EFXEquifax, Inc. 3.64%169.792.0%$167.12m
CPRTCopart, Inc. 2.19%106.394.4%$129.03m
BAHBooz Allen Hamilton Holding Corp. 0.05%76.722.0%$126.28m
PAGSPagSeguro Digital Ltd. 0.83%53.070.0%$121.52m
PRAHPRA Health Sciences, Inc. 2.51%146.442.4%$117.42m
CDAYCeridian HCM Holding, Inc. 1.81%84.320.0%$110.77m
ITGartner, Inc. 3.07%183.232.5%$102.66m
TRXCTransEnterix, Inc. -0.74%4.055.3%$101.94m
CRLCharles River Laboratories International, Inc. 1.94%273.374.5%$96.65m
BRBroadridge Financial Solutions, Inc. 2.38%142.481.5%$93.88m

Company Profile

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.